ACA
CLVS

Apis Capital Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Apis Capital Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3.29M Buy
+35,750
New +$3.09M 4.55% 7

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Apis Capital Advisors's CLVS Position: Q3 2015 in Review

Apis Capital Advisors opened a new position in Clovis Oncology, Inc. (CLVS) in Q3 2015: 35,750 shares worth $3.29M. The stake represents 4.55% of the portfolio and ranks #7 among its holdings.

192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • Apis Capital Advisors held 35,750 shares of Clovis Oncology, Inc. worth $3.29M as of Q3 2015.
  • Clovis Oncology, Inc. was a new Apis Capital Advisors position in Q3 2015.
  • Clovis Oncology, Inc. made up 4.55% of Apis Capital Advisors's portfolio in Q3 2015, its #7 holding.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.